Assessment of platelet function in the laboratory
- 1 January 2009
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hamostaseologie
- Vol. 29 (01), 25-31
- https://doi.org/10.1055/s-0037-1616935
Abstract
Platelet function testing is essential for the diagnosis of congenital/acquired bleeding disorders and may be useful for the prediction of surgical bleeding. Nowadays there is also much interest in monitoring the efficacy of anti-platelet therapy and measuring platelet hyper-function. However, this often presents clinical laboratories with significant challenges as platelet function tests are complex, poorly standardized, time consuming and quality assurance is not straightforward. There are also few comprehensive modern guidelines available and many recent published surveys have revealed poor standardization between laboratories. Up until the late 1980’s the traditional clinical platelet function tests that were available were the bleeding time (BT), light transmission (LTA) and whole blood aggregometry (WBA) and various biochemical assays. These were also usually performed within specialized research and clinical laboratories. Since the last BCSH guidelines were published in 1988 a variety of new platelet function tests have become available. These include flow cytometry and an ever increasing choice of new commercial instruments. Although the potential clinical utility of the new assays is emerging some have not yet entered into routine clinical practice. It is encouraging that a number of standardization committees (e. g. CLSI, BCSH and ISTH Platelet Physiology SSC) are now beginning to produce new platelet function testing guidelines and this will hopefully improve clinical practice, quality assurance and result in less variability between different laboratories.Keywords
This publication has 30 references indexed in Scilit:
- Aspirin Resistance and Adverse Clinical Events in Patients with Coronary Artery DiseaseAmerican Journal Of Medicine, 2007
- Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACSJournal of Thrombosis and Haemostasis, 2006
- Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseasesJournal of Thrombosis and Haemostasis, 2004
- Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial InfarctionCirculation, 2004
- Are the bleeding time and PFA‐100® useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?Journal of Thrombosis and Haemostasis, 2004
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- In Vitro Measurement of High-Shear Platelet Adhesion and Aggregation by the PFA-100®Published by Springer Nature ,2003
- In vitro aspirin resistance detected by PFA‐100TM closure time: pivotal role of plasma von Willebrand factorBritish Journal of Haematology, 2003
- Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study.Platelets, 2003
- Utility of the PFA‐100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitationsHaemophilia, 2001